Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Semaglutide works by mimicking GLP-1, a hormone that helps control blood sugar levels by causing the pancreas to release insulin, decreasing the production of glucagon, and slowing down the emptying of the stomach
10.1152/ajpendo.00471.2005 Am J Physiol Endocrinol Metab
For a broader view of related compounds, the GLP-3 peptide and amylin receptor agonist guides cover emerging targets in the metabolic peptide space that may eventually offer weight loss with fewer side effects
Its peptide structure enables it to activate both GIP and GLP-1 receptors, making it different from traditional GLP-1 medications and many other peptide therapies
Glucagon-like peptide-1 naturally releases from intestinal cells after eating, signaling the pancreas to produce insulin in a glucose-dependent manner
